HUO Kang,TAN Ying, YAN Xue-Zhen, ZHEN Lei, JIAN Zhi-Jie, YU Li-Ping, CHEN Chen. A Case of Fatal Young Vertebral Artery Dissection with Homocysteine Metabolism Gene Mutation[J]. Chinese Journal of Stroke, 2020, 15(10): 1062-1066.
[1] EKKER M S,BOOT E M,SINGHAL A B,etal. Epidemiology,aetiology,and management ofischaemic stroke in young adults[J]. Lancet Neurol,2018,17(9):790-801.[2] SCHIEVINK W I. Spontaneous dissection of thecarotid and vertebral arteries[J]. N Engl J Med,2001,344(12):898-906.[3] SCHWARTZ N E,VERTINSKY A T,HIRSCH KG,et al. Clinical and radiographic natural history ofcervical artery dissections[J]. J Stroke CerebrovascDis,2009,18(6):416-423.[4] GUILLON B,TZOURIO C,BIOUSSE V,et al.Arterial wall properties in carotid artery dissection:an ultrasound study[J]. Neurology,2000,55(5):663-666.[5] SILBERT P L,MOKRI B,SCHIEVINK W I.Headache and neck pain in spontaneous internalcarotid and vertebral artery dissections[J]. Neurology,1995,45(8):1517-1522.[6] CRUM B,MOKRI B,FULGHAM J. Spinalmanifestations of vertebral artery dissection[J].Neurology,2000,55(2):304-306.[7] SAW A E,MCINTOSH A S,KOUNTOURIS A.Vertebral artery dissection in sport:expert opinionof mechanisms and risk-reduction strategies[J/OL]. JClin Neurosci,2019,68:28-32[2020-06-15].https://doi.org/10.1016/j.jocn.2019.07.016.[8] URASYANANDANA K,SONGSANG D,AURBOONYAWAT T,et al. Treatment outcomesin cerebral artery dissection and literature review[J].Interv Neuroradiol,2018,24(3):254-262.[9] GOTTESMAN R F,SHARMA P,ROBINSON KA,et al. Imaging characteristics of symptomaticvertebral artery dissection:a systematic review[J].Neurologist,2012,18(5):255-260.[10] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国颈部动脉夹层诊治指南2015[J]. 中华神经科杂志,2015,48(8):644-651.[11] HANELINE M T,ROSNER A L. The etiology ofcervical artery dissection[J]. J Chiropr Med,2007,6(3):110-120.[12] PEZZINI A,DEL Z E,PADOVANI A.Hyperhomocysteinemia:a potential risk factor forcervical artery dissection following chiropracticmanipulation of the cervical spine[J]. J Neurol,2002,249(10):1401-1403[13] OLTEANU H,BANERJEE R. Human methioninesynthase reductase,a soluble P-450 reductaselikedual flavoprotein,is sufficient for NADPHdependentmethionine synthase activation[J]. J BiolChem,2001,276(38):35558-35563.[14] BROWN C A,MCKINNEY K Q,KAUFMAN JS,et al. A common polymorphism in methioninesynthase reductase increases risk of prematurecoronary artery disease[J]. J Cardiovasc Risk,2000,7(3):197-200.[15] KIM Y J,LEE J K,AHN S H,et al.Nonatheroscleotic isolated middle cerebral arterydisease may be early manifestation of moyamoyadisease[J]. Stroke,2016,47(9):2229-2235.[16] FROSST P,BLOM H J,MILOS R,et al. Acandidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolatereductase[J]. Nat Genet,1995,10(1):111-113.[17] WILCKEN B,BAMFORTH F,LI Z,et al.Geographical and ethnic variation of the 677C>Tallele of 5,10 methylenetetrahydrofolate reductase(MTHFR):findings from over 7000 newborns from16 areas world wide[J]. J Med Genet,2003,40(8):619-625.[18] KLOSS M,WIEST T,HYRENBACH S,et al.MTHFR 677TT genotype increases the risk forcervical artery dissections[J]. J Neurol NeurosurgPsychiatry,2006,77(8):951-952.[19] WU P P,TANG R N,AN L. A meta-analysis ofMTRR A66G polymorphism and colorectal cancersusceptibility[J]. J BUON,2015,20(3):918-922.[20] GAUGHAN D J,KLUIJTMANS L A,BARBAUXS,et al. The methionine synthase reductase(MTRR)A66G polymorphism is a novel genetic determinantof plasma homocysteine concentrations[J].Atherosclerosis,2001,157(2):451-456.[21] HOBBS C A,SHERMAN S L,YI P,et al.Polymorphisms in genes involved in folatemetabolism as maternal risk factors for Downsyndrome[J]. Am J Hum Genet,2000,67(3):623-630.